High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
NCT ID: NCT02873364
Last Updated: 2016-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
80 participants
INTERVENTIONAL
2016-08-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
NCT01371877
A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria
NCT03991845
Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation
NCT02742805
Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema
NCT00876369
Vitamin D and Grass Pollen Specific Immunotherapy
NCT01466465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3 (Low dose)
Daily 600 unites of vitamin D + Cetirizine 10mg twice a day
Vitamin D3 (Low dose)
Daily 600 unites vitamin D
Vitamin D3 (High dose)
Daily 4000 unites vitamin D + Cetirizine 10mg twice a day
Vitamin D3 (High dose)
Daily 4000 unites vitamin D
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3 (High dose)
Daily 4000 unites vitamin D
Vitamin D3 (Low dose)
Daily 600 unites vitamin D
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shiraz University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keramatallah Jahanshahi
Resident of internal medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keramatallah Jahanshahi, MD
Role: PRINCIPAL_INVESTIGATOR
Shiraz University of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shiraz University of Medical Sciences
Shiraz, Fars, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
93-01-01-8312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.